Management of drug-resistant cyathostominosis on a breeding farm in central North Carolina.

Autor: Little D; Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, North Carolina 27606, USA., Flowers JR, Hammerberg BH, Gardner SY
Jazyk: angličtina
Zdroj: Equine veterinary journal [Equine Vet J] 2003 May; Vol. 35 (3), pp. 246-51.
DOI: 10.2746/042516403776148264
Abstrakt: Reasons for Performing Study: Possible anthelmintic resistance on a breeding farm where a rapid rotation anthelmintic programme had been implemented for 9 years was investigated. Cyathostomins resistant to fenbendazole and pyrantel were documented by faecal worm egg count reduction test (FWECRT).
Objectives: To 1) manage small strongyle transmission in a herd of horses in which resistance to both pyrantel pamoate and fenbendazole was identified and thereby reduce the risk of clinical disease in the individual animal, 2) monitor the change in resistance patterns over time and 3) monitor the efficacy of ivermectin over the study period.
Methods: Targeted ivermectin treatment of horses on the farm was instituted for mature horses with faecal worm egg counts (FWEC) > 200 eggs/g (epg) and for horses < age 2 years with FWEC > 100 epg.
Results: Over a 30 month period, targeted ivermectin treatment achieved acceptable control in mares, as judged by FWEC, and improved control of patent cyathostome infection in consecutive foal crops. Egg reappearance time (ERT) after treatment with ivermectin was < 8 weeks in mares and foals more frequently in the second year of the study than in the first year. Numbers of anthelmintic treatments were reduced by 77.6 and 533% in the mare and foal group, respectively.
Conclusions: Targeted ivermectin treatment may be an economically viable method of managing multiple drug resistant cyathostominosis.
Potential Relevance: Use of ivermectin should be monitored closely for development of resistance.
Databáze: MEDLINE
Externí odkaz: